Church & Dwight Co., Inc. -- 5.9/10

HOLD
NYSE: CHD  |  Defensive consumer-staples compounder with oligopoly positions in niche categories -- Trojan (~75% US sexual health), baking soda (~70%+ category creator). But these gate-passing segments are CHD's smallest/slowest themes; its largest brand (ARM & HAMMER laundry, ~25% of revenue) is a #3 follower. Mixed financial trends: organic revenue re-accelerating (+5% Q1'26) but reported revenue decelerating, margins expanding but quarterly FCF margin compressing. All quality gates PASS.
Organic Revenue
+5.0%
Q1'26 | Re-accelerating | But reported decelerating
Adj Gross Margin
46.4%
Record | +130bps YoY
FY2025 FCF
$1,093M
+12% YoY | Growing
Fwd P/E
25.8x
At/above staples peers | No cushion
Company stats
CEO Rick Dierker (since Apr 2025) CFO Scott McChesney (since Mar 2025)
FY2025 Revenue ~$6.2B FYE December 31
Trojan Share ~75% US sexual health ARM & HAMMER Baking Soda ~70%+ category share
Quality Gate PASS (0 NOs)
Score breakdown
6
/ 10
Financial Trends Weight: 25% | Weighted: 1.50
Organic revenue re-accelerating to +5% in Q1'26 after a weak FY2025, but reported revenue still decelerating. Adj gross margin at record 46.4% (+130bps YoY). FY2025 FCF of $1,093M (+12% YoY) is strong and growing. However, quarterly FCF margin compressing and reported top-line trends remain mixed. The re-acceleration in organics is encouraging but needs to translate to reported revenue growth for a higher score.
5
/ 10
Thematic Exposure Weight: 35% | Weighted: 1.75
The gate-passing oligopoly positions (Trojan ~75%, baking soda ~70%+) are CHD's smallest and slowest-growing segments. The largest brand -- ARM & HAMMER laundry at ~25% of revenue -- is a #3 follower in a mature category. No exposure to high-growth secular mega-trends. Portfolio is well-constructed for defensive compounding but lacks the thematic tailwinds that drive above-average scores.
7
/ 10
Management Quality Weight: 20% | Weighted: 1.40
New CEO Rick Dierker (since April 2025, promoted from CFO) and new CFO Scott McChesney (since March 2025). Dierker has deep institutional knowledge from 12+ years at CHD. Proven beat-and-raise cadence through 2024. Decisive portfolio actions: divested Vitamins, exited Flawless and Showerheads, acquired Touchland. Exceptional tariff mitigation ($190M exposure reduced to $25M). Evergreen algorithm maintained for nearly a decade.
4
/ 10
Investor Sentiment Weight: 5% | Weighted: 0.20
Crowded Buy consensus with no contrarian edge. The sentiment setup offers limited upside from a positioning standpoint -- most of the Street is already constructive, leaving little room for positive re-rating from analyst upgrades. Premium valuation at 25.8x forward P/E relative to staples peers means the bar for positive surprise is high. No capitulation or washout visible in institutional positioning.
7
/ 10
Concerns & Risks Weight: 15% | Weighted: 1.05
Risk profile is well-managed. Tariff exposure mitigated from $190M to $25M. Balance sheet conservative at 1.5x leverage. Portfolio cleanup removes the weakest assets. Risks include SAP ERP transition (2026-2027), elevated HPC promotional environment, and the structural challenge that dominant categories have small TAMs. Catalysts include Touchland scaling, TheraBreath toothpaste launch, and ARM & HAMMER $2B-to-$3B roadmap.
Dimension Score Weight Weighted
Financial Trends 6 25% 1.50
Thematic Exposure 5 35% 1.75
Management Quality 7 20% 1.40
Investor Sentiment 4 5% 0.20
Concerns & Risks 7 15% 1.05
Composite 100% 5.9
Investment thesis

A defensive compounder that clears all quality gates on niche oligopoly positions (Trojan, baking soda) but lands below-average because: (1) the gate-passing segments are its smallest themes while its largest brand is a #3 follower (Thematic 5/10), (2) the sentiment setup is crowded Buy with no contrarian edge (4/10), and (3) financial trends are mixed with decelerating reported revenue despite re-accelerating organics (6/10).

Quality gate: ALL PASS (0 NOs).

Data sourced from Daloopa (company_id: 325). Analysis date: 2026-06-27.